Complete API Portfolio
181 API entries, including Q4 2026 additions. New regulatory documentation is awaiting confirmation.
Download PDF ↓Intermediates & synthesis references
Pharmaceutical intermediates
Intermediates & synthesis references
Explore intermediates and synthesis references by target API, CAS number or production stage. Identity, availability and documentation are confirmed for each enquiry.
Request Documentation →Updated 29 October 2026
640catalogue entries
178target groups
✓Project-specific documentation review
The target API identifies the synthesis project, not an offer of the finished API. API references are labelled separately. CAS and form clarifications are confirmed before quotation.
PDF DOWNLOADS
Product catalogues & company profile
Intermediates Portfolio
640 catalogue entries grouped by target API, with production stages where supplied.
Download PDF ↓Company Profile & API Portfolio
Company overview, selected experience, international network and complete API portfolio.
Download PDF ↓CEP & EU-DMF API List
The focused list of APIs with CEP and/or EU-DMF indicated in the existing portfolio.
Download PDF ↓Intermediates & synthesis references
Explore the portfolio
CarfilzomibOncology6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 247068-82-2 | Commercial | Intermediate | - | - |
| 247068-85-5 | Commercial | Intermediate | - | - |
| 868539-98-4 | Commercial | Intermediate | - | - |
| 868539-99-5 | Commercial | Intermediate | - | - |
| 868540-15-2 | Lab scale | Intermediate | - | - |
| 1140908-89-9 | Commercial | Intermediate | - | - |
Eribulin MesylateOncology15 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1960458-56-3 | Commercial | Intermediate | - | - |
| 137688-20-1 | Commercial | Intermediate | - | - |
| 1808153-91-4 | Commercial | Intermediate | - | - |
| 1808153-90-3 | Commercial | Intermediate | - | - |
| 2835443-65-5 | Commercial | Intermediate | - | - |
| 253128-14-2 | Commercial | Intermediate | - | - |
| 871360-33-7 | Commercial | Intermediate | - | - |
| 253128-15-3 | Commercial | Intermediate | - | - |
| 157322-83-3 | Commercial | Intermediate | - | - |
| 253128-41-5 | Commercial | Intermediate | - | - |
| 157322-47-9 | Commercial | Intermediate | - | - |
| 871360-42-8 | Commercial | Intermediate | R isomer as listed | - |
| 871360-43-9 | Commercial | Intermediate | S isomer as listed | - |
| 481048-22-0 | Commercial | Intermediate | - | - |
| 871348-24-2 | Commercial | Intermediate | - | - |
Ribociclib SuccinateOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1211443-61-6 | Commercial | Intermediate | - | - |
| 1211443-58-1 | Commercial | Intermediate | - | - |
PalbociclibOncology8 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 733039-20-8 | Commercial | Intermediate | - | - |
| 1013916-37-4 | Commercial | Intermediate | - | - |
| 1016636-76-2 | Commercial | Intermediate | - | - |
| 571189-16-7 | Commercial | Intermediate | - | - |
| 571188-59-5 | Commercial | Intermediate | - | - |
| 571188-82-4 | Pilot | Intermediate | - | - |
| 866084-31-3 | Commercial | Intermediate | - | - |
| 571190-30-2 | Commercial | API reference | Also listed in the API portfolio | - |
SotorasibOncology4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 78495-63-3 | Commercial | Intermediate | - | - |
| 1534369-41-9 | Commercial | Intermediate | - | - |
| 2252415-10-2 | Commercial | Intermediate | - | - |
| 1698293-93-4 | Lab scale | Intermediate | - | - |
TrabectedinOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 182201-71-4 | Commercial | Intermediate | - | - |
| 114899-80-8 | Commercial | Intermediate | - | - |
TemozolomideOncology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 72-40-2 | Commercial | Intermediate | - | - |
Bazedoxifene AcetateOncology4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 328933-65-9 | Commercial | Intermediate | - | - |
| 223251-25-0 | Commercial | Intermediate | - | - |
| 198479-63-9 | Commercial | Intermediate | - | - |
| 198480-21-6 | Commercial | Intermediate | - | - |
Lenvatinib MesylateOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 417721-36-9 | Commercial | Intermediate | - | - |
| 52671-64-4 | Commercial | Intermediate | - | - |
| 17609-80-2 | Commercial | Intermediate | - | - |
ElacestrantOncology8 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 32263-70-0 | Commercial | Intermediate | - | - |
| 722536-73-4 | Commercial | Intermediate | - | - |
| 2477812-43-2 | Commercial | Intermediate | - | - |
| 722520-36-7 | Commercial | Intermediate | - | - |
| 2477812-39-6 | Commercial | Intermediate | - | - |
| 2477812-42-1 | Commercial | Intermediate | - | - |
| 59557-92-5 | Commercial | Intermediate | - | - |
| 129968-11-2 | Commercial | Intermediate | - | - |
PacritinibOncology5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 859517-90-1 | Commercial | Intermediate | - | - |
| 110837-53-1 | Commercial | Intermediate | - | - |
| 937273-31-9 | Commercial | Intermediate | - | - |
| 937273-29-5 | Commercial | Intermediate | - | - |
| 937273-33-1 | Commercial | Intermediate | - | - |
AbemaciclibOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1231930-33-8 | Commercial | Intermediate | - | - |
| 1180132-17-5 | Commercial | Intermediate | - | - |
| 53617-35-9 | Commercial | Intermediate | - | - |
RemibrutinibOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1418128-33-2 | Commercial | Intermediate | - | - |
| 1787294-51-2 | Commercial | Intermediate | - | - |
| 1787294-47-6 | Commercial | Intermediate | - | - |
/ KT-474Oncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1224944-77-7 | Commercial | Intermediate | - | - |
| 2304754-51-4 | Commercial | Intermediate | - | - |
MuvalaplinOncology7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2565657-87-4 | Commercial | Intermediate | - | - |
| 2565657-72-7 | Commercial | Intermediate | - | - |
| 2565657-65-8 | Commercial | Intermediate | - | - |
| 2565657-49-8 | Commercial | Intermediate | - | - |
| 2565657-41-0 | Commercial | Intermediate | - | - |
| 2565657-34-1 | Commercial | Intermediate | - | - |
| 204688-60-8 | Commercial | Intermediate | - | - |
CamizestrantOncology5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2222845-71-6 | Commercial | Intermediate | - | - |
| 2142634-01-1 | Commercial | Intermediate | - | - |
| 2222846-05-9 | Commercial | Intermediate | - | - |
| 2222845-47-6 | Commercial | Intermediate | - | - |
| 1538772-53-0 | Commercial | Intermediate | - | - |
DaraxonrasibOncology4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2641451-73-0 | Commercial | Intermediate | - | - |
| 380223-17-6 | Commercial | Intermediate | - | - |
| 317845-81-1 | Commercial | Intermediate | - | - |
| 2641451-61-6 | Commercial | Intermediate | - | - |
VenetoclaxOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1228780-72-0 | Commercial | Intermediate | - | - |
| 1235865-75-4 | Commercial | Intermediate | - | - |
| 1228779-96-1 | Commercial | Intermediate | - | - |
Alectinib HydrochlorideOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1256584-73-2 | Commercial | Intermediate | - | - |
| 1256584-75-4 | Commercial | Intermediate | - | - |
| 114344-00-2 | Commercial | Intermediate | - | - |
NiraparibOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1171197-20-8 | Commercial | Intermediate | - | - |
| 4156-00-7 | Commercial | Intermediate | - | - |
ZanubrutinibOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1785348-09-5 | Commercial | Intermediate | - | - |
| - | Commercial | Intermediate | - | - |
RMC-5127Oncology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 3104671-22-6 | Commercial | Intermediate | - | - |
JNJ-2113Oncology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 66-99-9 | Commercial | Intermediate | - | - |
GarsorasibOncology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 309915-46-6 | Commercial | Intermediate | - | - |
LarotrectinibOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1218935-59-1 | Commercial | Intermediate | - | - |
| 1919868-77-1 | Commercial | Intermediate | - | - |
| 100243-39-8 | Commercial | Intermediate | - | - |
Trilaciclib HydrochlorideOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 571189-49-6 | Commercial | Intermediate | - | - |
| 1297537-45-1 | Commercial | Intermediate | - | - |
| 1297537-37-1 | Commercial | Intermediate | - | - |
RuxolitinibOncology7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1146629-75-5 | Commercial | Intermediate | - | - |
| 1029716-44-6 | Commercial | Intermediate | - | - |
| 591769-05-0 | Commercial | Intermediate | - | - |
| 1092939-17-7 | Commercial | API reference | Also listed in the API portfolio | - |
| 941678-49-5 | Commercial | Intermediate | - | - |
| 1153949-38-2 | Commercial | Intermediate | - | - |
| 1236033-05-8 | Commercial | Intermediate | - | - |
CrizotinibOncology5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 877397-65-4 | Commercial | Intermediate | - | - |
| 877399-00-3 | Commercial | Intermediate | - | - |
| 877399-74-1 | Commercial | Intermediate | - | - |
| 877399-52-5 | Commercial | Intermediate | - | - |
| 877399-51-4 | Commercial | Intermediate | - | - |
LorlatinibOncology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1454847-96-1 | Commercial | Intermediate | - | - |
AsciminibOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2799-21-5 | Commercial | Intermediate | - | - |
| 39065-95-7 | Commercial | Intermediate | - | - |
EnzalutamideOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1289942-66-0 | Commercial | Intermediate | - | - |
| 143782-23-4 | Commercial | Intermediate | - | - |
OlaparibOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 763113-22-0 | Commercial | Intermediate | - | - |
| 763111-47-3 | Commercial | Intermediate | - | - |
CabozantinibOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 849217-68-1 | Commercial | Intermediate | - | - |
| 1140909-48-3 | Commercial | Intermediate | - | - |
| 190728-25-7 | Commercial | Intermediate | - | - |
TrametinibOncology5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1187431-43-1 | Commercial | Intermediate | - | - |
| 871700-17-3 | Commercial | Intermediate | - | - |
| 871700-25-3 | Commercial | Intermediate | - | - |
| 871700-24-2 | Commercial | Intermediate | - | - |
| 871700-22-0 | Commercial | Intermediate | - | - |
LazertinibOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1903008-80-9 | Commercial | Intermediate | - | - |
| 1903009-56-2 | Commercial | Intermediate | - | - |
TovorafenibOncology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1096708-71-2 | Commercial | Intermediate | - | - |
| 1095823-62-3 | Commercial | Intermediate | - | - |
VismodegibOncology11 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 879085-55-9 | Commercial | Intermediate | - | - |
| 879088-41-2 | Commercial | Intermediate | - | - |
| 879088-40-1 | Commercial | Intermediate | - | - |
| 2642044-83-3 | Commercial | Intermediate | - | - |
| 2865162-10-1 | Commercial | Intermediate | - | - |
| 2641451-43-4 | Commercial | Intermediate | - | - |
| 2641451-78-5 | Commercial | Intermediate | - | - |
| 2641451-75-2 | Commercial | Intermediate | - | - |
| 14590-52-4 | Commercial | Intermediate | - | - |
| 1802150-57-7 | Commercial | Intermediate | - | - |
| 1802149-98-9 | Commercial | Intermediate | - | - |
GivinostatOncology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 199657-47-1 | Commercial | Intermediate | - | - |
| 840-65-3 | Commercial | Intermediate | - | - |
| 23138-53-6 | Commercial | Intermediate | - | - |
BivalirudinCardiovascular1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1450625-21-4 | Commercial | Intermediate | - | - |
TicagrelorCardiovascular4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 145783-15-9 | Commercial | Intermediate | - | - |
| 376608-65-0 | Commercial | Intermediate | - | - |
| 274693-54-8 | Commercial | Intermediate | - | - |
| 376608-74-1 | Commercial | Intermediate | - | - |
RivaroxabanCardiovascular6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 446292-07-5 | Commercial | Intermediate | - | - |
| 898543-06-1 | Commercial | Intermediate | - | - |
| 446292-08-6 | Commercial | Intermediate | - | - |
| 161596-47-0 | Commercial | Intermediate | - | - |
| 438056-69-0 | Commercial | Intermediate | - | - |
| 24065-33-6 | Commercial | Intermediate | - | - |
SacubitrilCardiovascular2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1426129-50-1 | Commercial | Intermediate | - | - |
| 149690-12-0 | Commercial | Intermediate | - | - |
VericiguatCardiovascular4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1350653-26-7 | Commercial | Intermediate | - | - |
| 6017-21-6 | Commercial | Intermediate | - | - |
| 1350653-30-3 | Commercial | Intermediate | - | - |
| 1350653-27-8 | Commercial | Intermediate | - | - |
PemafibrateCardiovascular2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 907192-60-3 | Commercial | Intermediate | - | - |
| 100841-00-7 | Commercial | Intermediate | - | - |
FinerenoneCardiovascular3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 21962-45-8 | Commercial | Intermediate | - | - |
| 65193-87-5 | Commercial | Intermediate | - | - |
| 95306-64-2 | Commercial | Intermediate | - | - |
Nebivolol HydrochlorideCardiovascular4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 129050-26-6 | Pilot | Intermediate | - | - |
| 129050-23-3 | Pilot | Intermediate | - | - |
| 197706-51-7 | Pilot | Intermediate | - | - |
| 197706-50-6 | Pilot | Intermediate | - | - |
RoxadustatCardiovascular2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1421312-33-5 | Pilot | Intermediate | - | - |
| 1421312-35-7 | Pilot | Intermediate | - | - |
ObicetrapibCardiovascular1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 4983-28-2 | Commercial | Intermediate | - | - |
RosuvastatinCardiovascular3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 147118-35-2 | Commercial | Intermediate | - | - |
| 2407463-90-3 | Commercial | Intermediate | - | - |
| 1306650-72-5 | Commercial | Intermediate | - | - |
Enlicitide DecanoateCardiovascular2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1190392-22-3 | Commercial | Intermediate | - | - |
| 1421271-01-3 | Commercial | Intermediate | - | - |
RiociguatCardiovascular1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 256499-19-1 | Commercial | Intermediate | - | - |
IvabradineCardiovascular3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 73942-87-7 | Commercial | Intermediate | - | - |
| 866783-13-3 | Commercial | Intermediate | - | - |
| 85175-59-3 | Commercial | Intermediate | - | - |
SelexipagCardiovascular7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 41270-66-0 | Commercial | Intermediate | - | - |
| 243472-70-0 | Commercial | Intermediate | - | - |
| 42042-66-0 | Commercial | Intermediate | - | - |
| 202658-88-6 | Commercial | Intermediate | - | - |
| 59504-75-5 | Commercial | Intermediate | - | - |
| 475086-75-0 | Commercial | Intermediate | - | - |
| 475085-57-5 | Commercial | Intermediate | - | - |
TafamidisCardiovascular5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 619-14-7 | Commercial | Intermediate | - | - |
| 2374-03-0 | Commercial | Intermediate | - | - |
| 51-36-5 | Commercial | Intermediate | - | - |
| 2905-62-6 | Commercial | Intermediate | - | - |
| 1184581-58-5 | Commercial | Intermediate | - | - |
AcroramidisCardiovascular2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2242751-53-5 | Commercial | Intermediate | - | - |
| 1446701-54-7 | Commercial | Intermediate | - | - |
NetarsudilCardiovascular5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1253952-02-1 | Commercial | Intermediate | - | - |
| 1254032-66-0 | Commercial | Intermediate | - | - |
| 1253955-19-9 | Commercial | Intermediate | - | - |
| 2097334-20-6 | Commercial | Intermediate | - | - |
| 23687-26-5 | Commercial | Intermediate | - | - |
RamelteonCentral Nervous System6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 196597-78-1 | Commercial | Intermediate | - | - |
| 196597-79-2 | Lab scale | Intermediate | - | - |
| 1029134-74-4 | Lab scale | Intermediate | - | - |
| 227179-22-8 | Lab scale | Intermediate | - | - |
| 196597-81-6 | Lab scale | Intermediate | - | - |
| 196597-80-5 | Lab scale | Intermediate | - | - |
SuvorexantCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 956317-36-5 | Commercial | Intermediate | - | - |
| 1266664-66-7 | Commercial | Intermediate | - | - |
| 1276666-12-6 | Commercial | Intermediate | - | - |
| 1620097-06-4 | Commercial | Intermediate | - | - |
VareniclineCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 4453-90-1 | Commercial | Intermediate | - | - |
| 230615-52-8 | Commercial | Intermediate | - | - |
| 230615-59-5 | Commercial | Intermediate | - | - |
| 230615-69-7 | Commercial | Intermediate | - | - |
VilazodoneCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 143612-79-7 | Commercial | Intermediate | - | - |
| 163521-20-8 | Commercial | Intermediate | - | - |
| 1422956-31-7 | Commercial | Intermediate | - | - |
| 183288-46-2 | Commercial | Intermediate | - | - |
RotigotineCentral Nervous System3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 58349-17-0 | Commercial | Intermediate | - | - |
| 93601-86-6 | Commercial | Intermediate | - | - |
| 439133-67-2 | Pilot | Intermediate | - | - |
MeptazinolCentral Nervous System1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 59891-41-7 | Commercial | Intermediate | - | - |
Centanafadine HydrochlorideCentral Nervous System1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 7498-57-9 | Pilot | Intermediate | - | - |
Lumateperone TosylateCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2098497-32-4 | Commercial | Intermediate | - | - |
| 1059630-13-5 | Commercial | Intermediate | - | - |
| 313368-85-3 | Commercial | Intermediate | - | - |
| 313544-31-9 | Commercial | Intermediate | - | - |
RimegepantCentral Nervous System10 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 39713-40-1 | Commercial | Intermediate | - | - |
| 1190363-45-1 | Commercial | Intermediate | CAS / salt-form clarification required | - |
| 1373116-06-3 | Commercial | Intermediate | - | - |
| 1190363-46-2 | Commercial | Intermediate | - | - |
| 781649-84-1 | Commercial | Intermediate | - | - |
| 1414976-14-9 | Commercial | Intermediate | - | - |
| 855778-84-6 | Commercial | Intermediate | - | - |
| 1190363-44-0 | Commercial | Intermediate | - | - |
| 1373116-05-2 | Commercial | Intermediate | - | - |
| 1374024-48-2 | Commercial | API reference | Also listed in the API portfolio | - |
ZavegepantCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 205058-78-2 | Commercial | Intermediate | - | - |
| 890044-58-3 | Commercial | Intermediate | - | - |
| 23995-88-2 | Commercial | Intermediate | - | - |
| 1456803-50-1 | Commercial | Intermediate | - | - |
Nemorexant(daridorexant hydrochloride)Central Nervous System7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 54413-93-3 | Commercial | Intermediate | - | - |
| 1293284-55-5 | Commercial | Intermediate | - | - |
| 1788104-76-6 | Commercial | Intermediate | - | - |
| 103336-06-7 | Commercial | Intermediate | - | - |
| 1508261-86-6 | Commercial | Intermediate | - | - |
| 673487-36-0 | Commercial | Intermediate | - | - |
| 1087743-89-2 | Commercial | Intermediate | - | - |
XanomelineCentral Nervous System2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 131986-28-2 | Commercial | Intermediate | - | - |
| 349535-15-5 | Commercial | Intermediate | - | - |
AticaprantCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 676494-56-7 | Commercial | Intermediate | - | - |
| 1213334-10-1 | Commercial | Intermediate | - | - |
| 676494-55-6 | Commercial | Intermediate | - | - |
| 383127-44-4 | Commercial | Intermediate | - | - |
SeltorexantCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1293284-71-5 | Commercial | Intermediate | - | - |
| 1186050-58-7 | Commercial | Intermediate | - | - |
| 111771-08-5 | Commercial | Intermediate | - | - |
| 848591-86-6 | Commercial | Intermediate | - | - |
SuzetrigineCentral Nervous System6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2649470-89-1 | Commercial | Intermediate | - | - |
| 1558274-26-2 | Commercial | Intermediate | - | - |
| 2875067-31-3 | Commercial | Intermediate | - | - |
| 2875066-35-4 | R&D | Intermediate | - | - |
| 2649470-87-9 | R&D | Intermediate | - | - |
| 2879218-02-5 | R&D | Intermediate | - | - |
MirogabalinCentral Nervous System5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1235479-59-0 | Commercial | Intermediate | - | - |
| 1235479-61-4 | Commercial | Intermediate | - | - |
| 1455358-16-3 | Commercial | Intermediate | - | - |
| 1456803-37-4 | Commercial | Intermediate | - | - |
| 2983019-93-6 | Commercial | Intermediate | - | - |
LemborexantCentral Nervous System2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 528587-70-4 | R&D | Intermediate | - | - |
| 1369767-20-3 | R&D | Intermediate | - | - |
Duloxetine HydrochlorideCentral Nervous System1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 132335-44-5 | Commercial | Intermediate | - | - |
Atogepant MonohydrateCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2413867-73-7 | Commercial | Intermediate | - | - |
| 500-22-1 | Commercial | Intermediate | - | - |
| 1455358-19-6 | Commercial | Intermediate | - | - |
| 1455358-11-8 | Commercial | Intermediate | - | - |
UbrogepantCentral Nervous System1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2136287-62-0 | Commercial | Intermediate | - | - |
RasagilineCentral Nervous System1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 10305-73-4 | Commercial | Intermediate | - | - |
OzanimodCentral Nervous System5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1306763-57-4 | Commercial | Intermediate | - | - |
| 1306763-31-4 | Commercial | Intermediate | - | - |
| 60899-34-5 | Commercial | Intermediate | - | - |
| 258273-31-3 | Commercial | Intermediate | - | - |
| 1618636-37-5 | Commercial | Intermediate | - | - |
PonesimodCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1029435-58-2 | Commercial | Intermediate | - | - |
| 854107-54-3 | Commercial | Intermediate | - | - |
| 854107-53-2 | Commercial | Intermediate | - | - |
| 1563017-36-6 | Commercial | Intermediate | - | - |
FingolimodCentral Nervous System7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 162358-05-6 | Commercial | Intermediate | - | - |
| 162358-06-7 | Commercial | Intermediate | - | - |
| 162358-07-8 | Commercial | Intermediate | - | - |
| 162358-08-9 | Commercial | Intermediate | - | - |
| 249289-10-9 | Commercial | Intermediate | - | - |
| 162359-95-7 | Commercial | Intermediate | - | - |
| 162359-56-0 | Commercial | API reference | Also listed in the API portfolio | - |
SiponimodCentral Nervous System5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 957205-24-2 | Commercial | Intermediate | - | - |
| 1378888-43-7 | Commercial | Intermediate | - | - |
| 36476-78-5 | Commercial | Intermediate | - | - |
| 1230487-01-0 | Commercial | Intermediate | - | - |
| 1234627-85-0 | Commercial | Intermediate | - | - |
BrexpiprazoleCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 70500-72-0 | Commercial | Intermediate | - | - |
| 913613-82-8 | Commercial | Intermediate | - | - |
| 5118-13-8 | Commercial | Intermediate | - | - |
| 913614-18-3 | Commercial | Intermediate | - | - |
TasimelteonCentral Nervous System5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 289058-20-4 | Commercial | Intermediate | - | - |
| 230642-84-9 | Commercial | Intermediate | - | - |
| 252577-77-8 | Commercial | Intermediate | - | - |
| 452324-76-4 | Commercial | Intermediate | - | - |
| 1400898-49-8 | Commercial | Intermediate | - | - |
Diroximel FumarateCentral Nervous System3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 18190-44-8 | Commercial | Intermediate | - | - |
| 2101811-41-8 | Commercial | Intermediate | - | - |
| 1577222-14-0 | Commercial | Intermediate | - | - |
RisdiplamCentral Nervous System4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 17412-23-6 | Commercial | Intermediate | - | - |
| 2133298-72-1 | Commercial | Intermediate | - | - |
| 2133298-73-2 | Commercial | Intermediate | - | - |
| 2133298-74-3 | Commercial | Intermediate | - | - |
OmaveloxoloneCentral Nervous System1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1192123-13-9 | Commercial | Intermediate | - | - |
FezolinetantEndocrine & Metabolic9 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 922178-61-8 | Lab scale | Intermediate | - | - |
| 1375066-73-1 | Commercial | Intermediate | - | - |
| 1383146-20-0 | Commercial | Intermediate | - | - |
| 1268364-46-0 | Commercial | Intermediate | - | - |
| 351227-42-4 | Commercial | Intermediate | - | - |
| 929048-29-3 | Commercial | Intermediate | - | - |
| 106910-77-4 | Commercial | Intermediate | - | - |
| 101376-25-4 | Commercial | Intermediate | - | - |
| 106973-36-8 | Commercial | Intermediate | - | - |
Teneligliptin hydrobromideEndocrine & Metabolic5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 89-25-8 | Commercial | Intermediate | - | - |
| 947-95-5 | Commercial | Intermediate | - | - |
| 401566-79-8 | Commercial | Intermediate | - | - |
| 84348-37-8 | Commercial | Intermediate | - | - |
| 401564-36-1 | Commercial | Intermediate | - | - |
Cinacalcet hydrochlorideEndocrine & Metabolic1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 21172-41-8 | Commercial | Intermediate | - | - |
AlfacalcidolEndocrine & Metabolic2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 112670-85-6 | Pilot | Intermediate | - | - |
| 65445-14-9 | Pilot | Intermediate | - | - |
EldecalcitolEndocrine & Metabolic6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 200636-54-0 | Lab scale | Intermediate | - | - |
| 2189732-17-8 | Lab scale | Intermediate | - | - |
| 66774-84-3 | Lab scale | Intermediate | - | - |
| 70550-73-1 | Lab scale | Intermediate | - | - |
| 144848-24-8 | Lab scale | Intermediate | - | - |
| 200636-42-6 | Lab scale | Intermediate | - | - |
CalcitriolEndocrine & Metabolic6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 111594-58-2 | Pilot | Intermediate | - | - |
| 128387-35-9 | Pilot | Intermediate | - | - |
| 169900-32-7 | Pilot | Intermediate | - | - |
| 73837-24-8 | Pilot | Intermediate | - | - |
| 140710-98-1 | Pilot | Intermediate | - | - |
| 140710-96-9 | Pilot | Intermediate | - | - |
MaxacalcitolEndocrine & Metabolic5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 81522-68-1 | Lab scale | Intermediate | - | - |
| 192573-37-8 | Lab scale | Intermediate | - | - |
| 884488-07-7 | Lab scale | Intermediate | - | - |
| 192573-33-4 | Lab scale | Intermediate | - | - |
| 81506-24-3 | Lab scale | Intermediate | - | - |
ParicalcitolEndocrine & Metabolic4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 139356-39-1 | Lab scale | Intermediate | - | - |
| 100858-26-2 | Lab scale | Intermediate | - | - |
| 1435939-17-5 | Lab scale | Intermediate | - | - |
| 1023889-38-4 | Lab scale | Intermediate | - | - |
25-OH Vitamin D2Endocrine & Metabolic1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 79396-56-8 | Lab scale | Intermediate | - | - |
CalcipotriolEndocrine & Metabolic4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 112849-17-9 | Commercial | Intermediate | - | - |
| 910133-70-9 | Commercial | Intermediate | - | - |
| 112849-27-1 | Commercial | Intermediate | - | - |
| 113082-99-8 | Commercial | Intermediate | - | - |
Linzagolix CholineEndocrine & Metabolic7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 450-93-1 | Commercial | Intermediate | - | - |
| 187543-87-9 | Commercial | Intermediate | - | - |
| 935287-59-5 | Commercial | Intermediate | - | - |
| 1581731-15-8 | Commercial | Intermediate | - | - |
| 1073435-71-8 | Commercial | Intermediate | - | - |
| 1073435-67-2 | Commercial | Intermediate | - | - |
| 121071-71-4 | Commercial | Intermediate | - | - |
RelugolixEndocrine & Metabolic5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2768834-98-4 | Commercial | Intermediate | - | - |
| 308831-94-9 | Commercial | Intermediate | - | - |
| 1589503-97-8 | Commercial | Intermediate | - | - |
| 7252-84-8 | Commercial | Intermediate | - | - |
| 1589503-95-6 | Commercial | Intermediate | - | - |
Elagolix SodiumEndocrine & Metabolic5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 102089-75-8 | Commercial | Intermediate | - | - |
| 830346-47-9 | Commercial | Intermediate | - | - |
| 830346-48-0 | Commercial | Intermediate | - | - |
| 1150560-54-5 | Commercial | Intermediate | - | - |
| 1150560-59-0 | Commercial | Intermediate | - | - |
Avatrombopag MaleateEndocrine & Metabolic4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 570407-10-2 | Commercial | Intermediate | - | - |
| 570407-42-0 | Commercial | Intermediate | - | - |
| 17766-28-8 | Commercial | Intermediate | - | - |
| 41667-95-2 | Commercial | Intermediate | - | - |
Eltrombopag OlamineEndocrine & Metabolic7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 376592-93-7 | Commercial | Intermediate | - | - |
| 376591-95-6 | Commercial | Intermediate | - | - |
| 376591-94-5 | Commercial | Intermediate | - | - |
| 18048-64-1 | Commercial | Intermediate | - | - |
| 277299-70-4 | Commercial | Intermediate | - | - |
| 98775-19-0 | Commercial | Intermediate | - | - |
| 688363-79-3 | Commercial | Intermediate | - | - |
ElinzanetantEndocrine & Metabolic5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 929047-29-0 | Commercial | Intermediate | - | - |
| 212650-43-6 | Commercial | Intermediate | - | - |
| 2642577-31-7 | Commercial | Intermediate | - | - |
| 289686-69-7 | Commercial | Intermediate | - | - |
| 825643-73-0 | Commercial | Intermediate | - | - |
OrforglipronEndocrine & Metabolic7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2212021-83-3 | Commercial | Intermediate | - | - |
| 2212021-81-1 | Commercial | Intermediate | - | - |
| 2212022-56-3 | Commercial | Intermediate | - | - |
| 2212021-61-7 | Commercial | Intermediate | - | - |
| 1784678-61-0 | Commercial | Intermediate | - | - |
| 2212021-59-3 | R&D | Intermediate | - | - |
| 2212021-79-7 | R&D | Intermediate | - | - |
Dapagliflozin propanediol monohydrateEndocrine & Metabolic6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 21739-92-4 | Commercial | Intermediate | - | - |
| 461432-23-5 | Commercial | Intermediate | - | - |
| 461432-25-7 | Commercial | Intermediate | - | - |
| 461432-26-8 | Commercial | Intermediate | - | - |
| 714269-57-5 | Commercial | Intermediate | - | - |
| 1103738-29-9 | Commercial | Intermediate | - | - |
VildagliptinEndocrine & Metabolic1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 7531-52-4 | Commercial | Intermediate | - | - |
Orforglipron Hemicalcium HydrateEndocrine & Metabolic3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1006381-03-8 | Commercial | Intermediate | - | - |
| 2212021-77-5 | Commercial | Intermediate | - | - |
| 2212020-52-3 | Commercial | Intermediate | - | - |
Canagliflozin hemihydrateEndocrine & Metabolic2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 866607-35-4 | Commercial | Intermediate | - | - |
| 898566-17-1 | Commercial | Intermediate | - | - |
EmpagliflozinEndocrine & Metabolic7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 915095-99-7 | Commercial | Intermediate | - | - |
| 1279691-36-9 | Commercial | Intermediate | - | - |
| 915095-94-2 | Commercial | Intermediate | - | - |
| 915095-89-5 | Commercial | Intermediate | - | - |
| 915095-87-3 | Commercial | Intermediate | - | - |
| 32384-65-9 | Commercial | Intermediate | - | - |
| 86087-23-2 | Commercial | Intermediate | - | - |
SotagliflozinEndocrine & Metabolic3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1018899-03-0 | Commercial | Intermediate | - | - |
| 1103738-30-2 | Commercial | Intermediate | - | - |
| 1103738-19-7 | Commercial | Intermediate | - | - |
IpragliflozinEndocrine & Metabolic3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 761423-87-4 | Commercial | Intermediate | - | - |
| 1034305-21-9 | Commercial | Intermediate | - | - |
| 1034305-17-3 | Commercial | Intermediate | - | - |
ErtugliflozinEndocrine & Metabolic1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1528636-39-6 | Commercial | Intermediate | - | - |
RepaglinideEndocrine & Metabolic2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 99469-99-5 | Commercial | Intermediate | - | - |
| 219921-94-5 | Commercial | Intermediate | - | - |
BaxrostatEndocrine & Metabolic4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1427587-32-3 | Commercial | Intermediate | - | - |
| 1092523-03-9 | Commercial | Intermediate | - | - |
| 1428652-00-9 | Commercial | Intermediate | - | - |
| 1428651-87-9 | Commercial | Intermediate | - | - |
Avibactam sodiumAnti-Infectives1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1192651-80-1 | Commercial | Intermediate | - | - |
PaxlovidAnti-Infectives7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 13726-69-7 | Commercial | Intermediate | - | - |
| 202477-59-6 | Commercial | Intermediate | - | - |
| 51154-06-4 | Commercial | Intermediate | - | - |
| 90104-21-5 | Commercial | Intermediate | - | - |
| 800412-56-0 | Commercial | Intermediate | - | - |
| 74844-93-2 | Commercial | Intermediate | - | - |
| 565456-77-1 | Commercial | Intermediate | - | - |
BifonazoleAnti-Infectives2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 7598-80-3 | Commercial | Intermediate | - | - |
| 2128-93-0 | Commercial | Intermediate | - | - |
FostemsavirAnti-Infectives2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 619331-35-0 | Lab scale | Intermediate | - | - |
| 446284-32-8 | Lab scale | Intermediate | - | - |
LenacapavirAnti-Infectives6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1620056-47-4 | Commercial | Intermediate | - | - |
| 2109226-54-0 | Commercial | Intermediate | - | - |
| 2189684-54-4 | Commercial | Intermediate | - | - |
| 2189684-53-3 | Commercial | Intermediate | - | - |
| 1620056-83-8 | Commercial | Intermediate | - | - |
| 2901-44-2 | Commercial | Intermediate | - | - |
Sitafloxacin hydrateAnti-Infectives1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 129306-06-5 | Commercial | Intermediate | - | - |
GepotidacinAnti-Infectives6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 527681-60-3 | Commercial | Intermediate | - | - |
| 527681-61-4 | Commercial | Intermediate | - | - |
| 1075238-01-5 | Commercial | Intermediate | - | - |
| 2169933-17-7 | Commercial | Intermediate | - | - |
| 1198016-28-2 | Commercial | Intermediate | - | - |
| 73874-95-0 | Commercial | Intermediate | - | - |
BrensocatibAnti-Infectives8 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1220696-32-1 | Commercial | Intermediate | - | - |
| 1273567-44-4 | Commercial | Intermediate | - | - |
| 1159489-37-8 | Commercial | Intermediate | - | - |
| 1802149-87-6 | Commercial | Intermediate | - | - |
| 868694-44-4 | Commercial | Intermediate | - | - |
| 289686-70-0 | Commercial | Intermediate | - | - |
| 218594-79-7 | Commercial | Intermediate | - | - |
| 825643-59-2 | Commercial | Intermediate | - | - |
LetermovirAnti-Infectives6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 917389-26-5 | Commercial | Intermediate | - | - |
| 1791412-01-5 | Commercial | Intermediate | - | - |
| 917389-21-0 | Commercial | Intermediate | - | - |
| 16015-70-6 | Commercial | Intermediate | - | - |
| 65896-11-9 | Commercial | Intermediate | - | - |
| 349-65-5 | Commercial | Intermediate | - | - |
BictegravirAnti-Infectives2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1279032-31-3 | Commercial | Intermediate | - | - |
| 214759-21-4 | Commercial | Intermediate | - | - |
VelpatasvirAnti-Infectives1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1378391-45-7 | Commercial | Intermediate | - | - |
SofosbuvirAnti-Infectives2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 817204-32-3 | Commercial | Intermediate | - | - |
| 863329-66-2 | Commercial | Intermediate | - | - |
PeramivirAnti-Infectives2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 229613-93-8 | Commercial | Intermediate | - | - |
| 316173-29-2 | Commercial | Intermediate | - | - |
Oseltamivir PhosphateAnti-Infectives1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 204254-96-6 | Commercial | Intermediate | - | - |
RemdesivirAnti-Infectives3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1191237-69-0 | Commercial | Intermediate | - | - |
| 1355357-49-1 | Commercial | Intermediate | - | - |
| 2136287-61-9 | Commercial | Intermediate | - | - |
Baloxavir MarboxilAnti-Infectives7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1985607-70-2 | Pilot | Intermediate | - | - |
| 1985607-83-7 | Pilot | Intermediate | - | - |
| 61477-40-5 | Commercial | Intermediate | - | - |
| 1335210-23-5 | Commercial | Intermediate | - | - |
| 98737-29-2 | Commercial | Intermediate | - | - |
| 866594-60-7 | Commercial | Intermediate | - | - |
| 253265-97-3 | Commercial | Intermediate | - | - |
Isavuconazonium SulfateAnti-Infectives5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 368421-58-3 | Commercial | Intermediate | - | - |
| 1180002-01-0 | Commercial | Intermediate | - | - |
| 241479-73-2 | Commercial | Intermediate | - | - |
| 20099-89-2 | Commercial | Intermediate | - | - |
| 338990-31-1 | Commercial | Intermediate | - | - |
Darunavir AmorphousAnti-Infectives5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 169280-56-2 | Commercial | Intermediate | - | - |
| 206361-99-1 | Commercial | Intermediate | - | - |
| 165727-45-7 | Commercial | Intermediate | - | - |
| 191226-98-9 | Commercial | Intermediate | - | - |
| 192725-55-6 | Commercial | Intermediate | - | - |
Dolutegravir SodiumAnti-Infectives1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 98760-08-8 | Commercial | Intermediate | - | - |
AtazanavirAnti-Infectives2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 162537-11-3 | Commercial | Intermediate | - | - |
| 198904-85-7 | Commercial | Intermediate | - | - |
TigecyclineAnti-Infectives1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 6939-23-7 | Commercial | Intermediate | - | - |
TorezolidAnti-Infectives6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 380380-64-3 | Commercial | Intermediate | - | - |
| 1056039-83-8 | Commercial | Intermediate | - | - |
| 444335-16-4 | Commercial | Intermediate | - | - |
| 856866-72-3 | Commercial | Intermediate | - | - |
| 1297537-41-7 | Commercial | Intermediate | - | - |
| 1297537-33-7 | Commercial | Intermediate | - | - |
EluxadolineGastroenterology7 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 56926-94-4 | Commercial | Intermediate | - | - |
| 93267-04-0 | Commercial | Intermediate | - | - |
| 623950-02-7 | Commercial | Intermediate | - | - |
| 6530-41-2 | Commercial | Intermediate | - | - |
| 1993394-57-2 | Commercial | Intermediate | - | - |
| 864825-23-0 | Commercial | Intermediate | - | - |
| 78515-16-9 | Commercial | Intermediate | - | - |
FexuprazanGastroenterology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2258638-52-5 | Commercial | Intermediate | - | - |
| 701-27-9 | Commercial | Intermediate | - | - |
| 2258638-53-6 | Commercial | Intermediate | - | - |
TegoprazanGastroenterology6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1270294-05-7 | Commercial | Intermediate | - | - |
| 942195-86-0 | Commercial | Intermediate | - | - |
| 1640981-19-6 | Commercial | Intermediate | - | - |
| 1640981-20-9 | Commercial | Intermediate | - | - |
| 2975125-72-3 | Commercial | Intermediate | - | - |
| 1640981-02-7 | Commercial | Intermediate | - | - |
ZastaprazanGastroenterology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2892564-07-5 | Lab scale | Intermediate | - | - |
ElobixibatGastroenterology5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 100048-86-0 | Commercial | Intermediate | - | - |
| 439089-27-7 | Commercial | Intermediate | - | - |
| 439088-74-1 | Commercial | Intermediate | - | - |
| 439088-16-1 | Pilot | Intermediate | - | - |
| 439088-73-0 | R&D | Intermediate | - | - |
Tenapanor HydrochlorideGastroenterology4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1870821-29-6 | Commercial | Intermediate | - | - |
| 5013-77-4 | Commercial | Intermediate | - | - |
| 929-59-9 | Commercial | Intermediate | - | - |
| 4538-37-8 | Commercial | Intermediate | - | - |
SeladelparGastroenterology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 256372-58-4 | Commercial | Intermediate | - | - |
| 91427-62-2 | Commercial | Intermediate | - | - |
ResmetiromGastroenterology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 920509-28-0 | Pilot | Intermediate | - | - |
| 107228-51-3 | R&D | Intermediate | - | - |
| 920509-27-9 | R&D | Intermediate | - | - |
Vonoprazan FumarateGastroenterology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 881677-11-8 | Pilot | Intermediate | - | - |
| 881674-56-2 | Commercial | Intermediate | - | - |
| 16133-25-8 | Commercial | Intermediate | - | - |
Obeticholic AcidGastroenterology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1516887-33-4 | Commercial | Intermediate | - | - |
| 915038-26-5 | Commercial | Intermediate | - | - |
FamotidineGastroenterology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 7803-58-9 | Commercial | Intermediate | - | - |
RebamipideGastroenterology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 13433-00-6 | Commercial | Intermediate | - | - |
| 1068-90-2 | Commercial | Intermediate | - | - |
| 5162-90-3 | Commercial | Intermediate | - | - |
ApremilastGastroenterology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 6296-53-3 | Commercial | Intermediate | - | - |
| 608141-43-1 | Commercial | Intermediate | - | - |
UpadacitinibImmunology5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1428243-26-8 | Commercial | Intermediate | - | - |
| 1869118-25-1 | Commercial | Intermediate | - | - |
| 1869118-24-0 | Commercial | Intermediate | - | - |
| 1201187-44-1 | Commercial | Intermediate | - | - |
| 1428243-24-6 | Commercial | Intermediate | - | - |
AbrocitinibImmunology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 23761-23-1 | Commercial | Intermediate | - | - |
| 130369-36-7 | Commercial | Intermediate | - | - |
| 2204290-99-1 | Commercial | Intermediate | - | - |
Peficitinib HydrobromideImmunology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 951625-93-7 | Commercial | Intermediate | - | - |
| 62058-03-1 | Commercial | Intermediate | - | - |
Iptacopan HydrochlorideImmunology6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1387445-50-2 | Commercial | Intermediate | - | - |
| 1481631-51-9 | Commercial | Intermediate | - | - |
| 2408761-23-7 | Commercial | Intermediate | - | - |
| 2408761-22-6 | Commercial | Intermediate | - | - |
| 1644667-61-7 | Commercial | Intermediate | - | - |
| 1644667-62-8 | Commercial | Intermediate | - | - |
RoflumilastImmunology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 151103-08-1 | Commercial | Intermediate | - | - |
| 151103-09-2 | Commercial | Intermediate | - | - |
DanicopanImmunology4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 203866-14-2 | Commercial | Intermediate | - | - |
| 886363-74-2 | Commercial | Intermediate | - | - |
| 1903745-21-0 | Commercial | Intermediate | - | - |
| 1052686-67-5 | Commercial | Intermediate | - | - |
TofacitinibImmunology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 479633-63-1 | Commercial | Intermediate | - | - |
| 3680-69-1 | Commercial | Intermediate | - | - |
| 3680-71-5 | Commercial | Intermediate | - | - |
BaricitinibImmunology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1187595-85-2 | Commercial | Intermediate | - | - |
| 1236033-21-8 | Commercial | Intermediate | - | - |
FilgotinibImmunology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1142943-96-1 | Commercial | Intermediate | - | - |
| 1092563-25-1 | Commercial | Intermediate | - | - |
ToceranibImmunology2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 874819-74-6 | Commercial | Intermediate | - | - |
| 356068-93-4 | Commercial | Intermediate | - | - |
BepotastineRespiratory4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 210095-66-2 | Commercial | Intermediate | - | - |
| 201594-84-5 | Commercial | Intermediate | - | - |
| 142404-69-1 | Commercial | Intermediate | - | - |
| 122368-54-1 | Commercial | Intermediate | - | - |
Ketotifen fumarateRespiratory2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1966-89-8 | Commercial | Intermediate | - | - |
| 59743-84-9 | Commercial | Intermediate | - | - |
Nintedanib EthanesulfonateRespiratory5 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 262368-30-9 | Commercial | Intermediate | - | - |
| 14192-26-8 | Commercial | Intermediate | - | - |
| 1168150-46-6 | Commercial | Intermediate | - | - |
| 2653-16-9 | Commercial | Intermediate | - | - |
| 676326-36-6 | Commercial | Intermediate | - | - |
NintedanibRespiratory1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1027407-75-5 | Commercial | Intermediate | - | - |
TezacaftorRespiratory4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 952664-69-6 | Commercial | Intermediate | - | - |
| 1092536-54-3 | Commercial | Intermediate | - | - |
| 1638771-94-4 | Commercial | Intermediate | - | - |
| 862574-88-7 | Commercial | Intermediate | - | - |
IvacaftorRespiratory2 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 13721-01-2 | Commercial | Intermediate | - | - |
| 873055-58-4 | Commercial | Intermediate | - | - |
LumacaftorRespiratory4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 25487-66-5 | Commercial | Intermediate | - | - |
| 68119-31-3 | Commercial | Intermediate | - | - |
| 442129-37-5 | Commercial | Intermediate | - | - |
| 936727-68-3 | Commercial | Intermediate | - | - |
ElexacaftorRespiratory4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2229861-15-6 | Commercial | Intermediate | - | - |
| 2229861-17-8 | Commercial | Intermediate | - | - |
| 1897428-37-3 | Commercial | Intermediate | - | - |
| 88398-53-2 | Commercial | Intermediate | - | - |
VanzacaftorRespiratory4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2229861-93-0 | Commercial | Intermediate | - | - |
| 2410062-97-2 | Commercial | Intermediate | - | - |
| 124433-70-1 | Commercial | Intermediate | - | - |
| 38496-18-3 | Commercial | Intermediate | - | - |
Sparsentan(FILSPARI)Urology & Gynecology6 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 415697-58-4 | Commercial | Intermediate | - | - |
| 415697-56-2 | Commercial | Intermediate | - | - |
| 837408-71-6 | Commercial | Intermediate | - | - |
| 948349-66-4 | Commercial | Intermediate | - | - |
| 1026913-68-7 | Commercial | Intermediate | - | - |
| 1098924-76-5 | Commercial | Intermediate | - | - |
LesinuradUrology & Gynecology1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 878671-99-9 | Commercial | Intermediate | - | - |
VibegronUrology & Gynecology4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 46032-98-8 | Commercial | Intermediate | - | - |
| 494224-44-1 | Commercial | Intermediate | - | - |
| 163625-46-5 | Commercial | Intermediate | - | - |
| 1426235-01-9 | Commercial | Intermediate | - | - |
CrisaboroleDermatology3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 2973-80-0 | Commercial | Intermediate | - | - |
| 906673-54-9 | Commercial | Intermediate | - | - |
| 906673-45-8 | Commercial | Intermediate | - | - |
FluralanerOther1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 55860-35-0 | Commercial | Intermediate | - | - |
MilvexianOther3 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 20626-49-7 | Commercial | Intermediate | - | - |
| 1802431-24-8 | Commercial | Intermediate | - | - |
| 1802430-55-2 | Commercial | Intermediate | - | - |
N-Methyl Glucamine AntimonateOther1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 133-51-7 | Commercial | Intermediate | - | - |
N-Ethyl-D-glucamineOther1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 14216-22-9 | Commercial | Intermediate | - | - |
OclacitinibOther1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1208319-27-0 | Commercial | Intermediate | - | - |
BardoxoloneOther1 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1191265-32-3 | Commercial | Intermediate | - | - |
GalNAc-L96Other4 results ＋
| CAS No. | Production stage | Entry type | Details | Documentation |
|---|---|---|---|---|
| 1159408-61-3 | Commercial | Intermediate | - | - |
| 1159408-62-4 | Commercial | Intermediate | - | - |
| 1159408-65-7 | Commercial | Intermediate | - | - |
| 1159408-70-4 | Commercial | Intermediate | - | - |
REGULATORY & QUALITY FRAMEWORK
Documentation, assessed product by product
Regulatory and technical documentation is assessed product by product and confirmed against the intended market, dosage form and customer project before supply.
CEPEU-DMFUS-DMFCEP in progress
Final status, validity, manufacturing site coverage and regulatory scope must be verified during project qualification. Availability is subject to project qualification, applicable regulation, intellectual property, destination territory, documentation and commercial availability.